Home > Riviste > Minerva Medica > Fascicoli precedenti > Minerva Medica 2021 February;112(1) > Minerva Medica 2021 February;112(1):81-95

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

REVIEW  ENDOMETRIAL CANCER 

Minerva Medica 2021 February;112(1):81-95

DOI: 10.23736/S0026-4806.20.07081-0

Copyright © 2020 EDIZIONI MINERVA MEDICA

lingua: Inglese

Quality of life and sexual functioning of patient affected by endometrial cancer

Stefano CIANCI 1 , Andrea ROSATI 2, Vito A. CAPOZZI 3, Mattia TARASCIO 4, Stefano UCCELLA 5, Marco PALUMBO 6, Salvatore CARUSO 6

1 Department of Woman, Child and General and Specialized Surgery, Luigi Vanvitelli University of Campania, Naples, Italy; 2 Department of Obstetrics and Gynecology, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy; 3 Department of Gynecology and Obstetrics, University of Parma, Parma, Italy; 4 ASL Catania, Catania, Italy; 5 Department of Obstetrics and Gynecology, AOUI Verona, University of Verona, Verona, Italy; 6 Department of General Surgery and Medical Surgical Specialties, University of Catania, Catania, Italy



INTRODUCTION: Thanks to timely diagnosis and medical advancement the number of endometrial cancer (EC) patients achieving long term survival is constantly increasing and here comes the necessity to move forward with the understanding of post-treatment sexual adjustment and with the strategies to enhance sexual functioning (SF) and quality of life (QoL) in this population. In this scenario we designed this study aiming to summarize and analyze the available scientific evidence regarding QoL and especially SF in patients affected by EC who underwent surgical and adjuvant treatment.
EVIDENCE ACQUISITION: A preliminary research was conducted using Pubmed database with specific keywords combinations regarding SF, QoL and endometrial cancer. The main findings considered in the present review were: the study design, the number of patients included in each study, the information about pathology (histology and stage of disease), the questionnaires administered and the principal results concerning SF and QoL.
EVIDENCE SYNTHESIS: A total of thirteen studies, between 2009 and 2018, treating the aspects of SF and QoL in patients affected by EC were extracted. The principal findings of different studies were organized in the following sections: 1) overall SF in EC patients (reasons for sexual inactivity); 2) impact of EC on SF when compared to benign gynecological disease or healthy controls-focus on surgery; 3) minimally invasive surgery versus classical laparotomic approach and SF of EC patients; 4) surgery alone versus VBT versus EBRT and SF of EC patients; 5) focus on RT; 6) the mutual correlation between sociodemographic, relational, psychological, clinical/metabolic factors and the SF of EC patients.
CONCLUSIONS: Considering the widespread diffusion of female sexual dysfunction among EC patients and the relatively good prognosis, especially in early stage disease, it undoubtedly looms the need for proactive countermeasures to maximize the sexual well-being and QoL of these patients. A wide range of intervention in a multi-modal physical and mental perspective should be considered.


KEY WORDS: Sexual dysfunctions, psychological; Quality of life; Endometrial neoplasms

inizio pagina